Bangladesh J Pharmacol. 2015; 10: 891-895.

DOI:10.3329/bjp.v10i4.23991

| Research | Article |

GC/MS analysis, antimicrobial and in vitro anti-cholinesterase activities of the essential oil from Buddleja asiatica

Farman Ali Khan1, Abdul Khaliq Jan1, Nasir Mehmood Khan1, Nayab Ali Khan2 and Shahnaz Khan2

1Department of Chemistry, Shaheed Benazir Bhutto University, Sheringal, Dir 18000, KP, Pakistan; 2Department of Chemistry, University of Science and Technology, Bannu 28100, KPK, Pakistan.

Principal Contact

Abstract

Buddleja asiatica essential oil from the leaves by hydrodistillation was subjected to gas chromatography/mass spectrometery analysis which revealed the presence of 17 constituents out of which 14 were identified as: four monoterpenes hydrocarbons, four oxygenated monoterpenes, one hydrocarbon sesquiterpenes and five oxygenated sesquiterpenes. The major constituent being found was 1,8-cineole (38.1%) while β-sinensal, 1, 10-seco-1-hydroxy-calamenen-10-one and α-phellandrene were found to be in 11.8%, 10.2% and 5.8%, respectively. The essential oil exhibited 66% strong antibacterial activity against Shigella boydii while in fungicidal assay, it revealed an outstanding 79% inhibition against Aspergillus flavus. The essential oil showed outstanding acetylcholinesterase (IC50 5.2 μM) and butyrylcholinesterase inhibitory effect (IC50 27.9 μM) as compared to standard drugs respectively.


Introduction

The genus Buddleja comprises of more than 100 species and belongs to family Scrophulariaceae (Hegnauer, 1962; Fathy et al., 2006). Buddleja plants are widely distributed throughout the world and only four species are found in Pakistan, i.e., B. asiatica, B. crispa, B. davidii and B. lindleyana (Abdullah, 1974). The ethnopharmacology of Buddleja species summarise major traditional medicinal uses such as anti-inflammatory, analgesic, antipyretic, anticataratic, antihepatotoxic, hypotencive, hypoglycaemic, neuroprotective, antimicrobial, mollusicidal and amebocidal activities (El-Domiatya et al., 2009). Theyhave been used in the treatment of cancer (Hu et al., 2001) and as a cure of articular rheumatism in the Chinese traditional medicine (Dictionary of Chinese Traditional Medicine, 1977). The whole plant B. asiatica has been used medicinally in skin complaints, to treat head tumour and malaria (Pande et al., 2007; Hartwell, 1970; Reis and Von, 1973). The essential oil of the leaves has been reported to posses in vitro antifungal activities (Garg and Dengre, 1992). The extracts of B. asiatica also showed strong cyclo-oxygenase (COX) inhibitory activities using elicited rat peritoneal leukocytes (Liao et al., 1999). Earlier, we reported the antimicrobial, antispasmodic, Ca++ antagonist and cholinesterase inhibitory potential of the plant B. asiatica, followed by the GC/MS analysis of the fixed oils (Ali et al., 2011; Ali et al., 2011; Ali et al., 2013; Ali et al., 2013). In this article, we report the GC/MS analysis, antimicrobial activities and cholinesterase inhibitory activities of the essential oil obtained from the leaves of B. asiatica. Fourteen of the constituents were identified out of the total seventeen. The mass spectral data and retention times of the constituents were analyzed by the data system library and confirmed by comparison of their mass spectra using NIST mass spectral search program or Kovat’s Retention Index (RI).


Materials and Methods

Plant material

The whole plant of B. asiatica was collected from Banda Piran, Siran valley (34° N/73° E, 2900 meters above the sea level), District Mansehra, in October, 2007. It was identified by Prof. Manzoor Ahmad, Plant Taxonomist, Department of Botany, Government Degree College, Abbotabad, Pakistan, where a voucher specimen has been deposited in the herbarium (accession No. B- 0015).

Volatile oil extraction

Fresh leaves (100 g) of B. asiatica were suspended in 5 L water and subjected to hydrodistillation for 4 hours using a clevenger-type apparatus for essential oil extraction. The resulted extracted oil (1%) was separated from water by extracting three times with ethyl acetate (300 mL) and was dried by filtration over anhydrous sodium sulfate. The oil was placed in sealed tubes and kept at 4°C (Shojaaddini et al., 2008).

Sample Preparation

One milligram of the sample was dissolved in 1 mL dichloromethane, mixed well and allowed to stand for 10 min. Alongside the samples, a method blank was also prepared and analyzed.

GC/MS analysis

An Agilent 7890A Series GC connected to a 5975C Inert XL mass selective detector (combined) was used to carry out GC/MS analysis. Splitless injector and the interface were maintained at 300°C and 340°C respectively. Helium gas was used as carrier gas (at constant inlet pressure). The oven temperature was programmed from 50°C to 350°C (2-10 min) at 10°C/min. The GC contained an HP-5MS 5% phenyl methyl siloxane phase fused silica column with a diameter of 15 m X 0.25 mm, 0.25 µm and was directly inserted into the ion source. A full scan at 70 eV from m/z 50 to 800 was carried out to obtain the electron impact (EI) spectra.

Antibacterial activity

B. asiatica essential oil was screened for their antibacterial assay against selected bacterial strains including; Escherichia coli (ATCC 25922), Bacillus subtilis (ATCC 6663), Staphylococcus aureus (ATCC 25923), Shigella boydii (ATCC 35966), Shigella flexneri (ATCC 14028), Pseudomonas aeruginosa (ATCC 27853) and Salmonella typhi (ATCC 19430) according to agar–well diffusion method (Rahman et al., 2011). Briefly, a loop full of 24 hours old culture containing approximately 104-106 CFU was spread on the surface of Mueller-Hinton Agar plates. The stock solutions of B. asiatica (1 mg/mL) were prepared in dimethylsulfoxide, followed by digging wells in the medium and adding 100 μL dilutions in the respective wells. Imepinem was used as positive control and reference compound.

Antifungal activity

B. asiatica essential oil was screened for their antifungal bioassay using agar well diffusion method (Duraipandiyan and Lgnacimuthu, 2009) against Aspergillus flavus (ATTC 32611), Microsporum canis (ATTC 11622), Ttichophyton longifusus (ATTC 22397), Fusarium solani (ATTC 11712), Candida glaberata (ATTC 90030) and Candida albicans (ATTC 2091). Briefly, the stock solutions of B. asiatica essential oil prepared in dimethyl sulfoxide. Sterile sabouraud’s dextrose agar medium (5 mL) was placed in a test tube and inoculated with the sample solutions (400 µg /mL) kept in slanting position at room temperature overnight. The fungal culture was then inoculated on the slant. The samples were incubated for 7 days at 29°C and growth inhibition was observed. Amphotericin-B and miconazole were used as the standard drugs.

Cholinesterase inhibition assay and determination of IC50 values

Acetylcholinesterase (AChE, EC 3.1.1.7), butyrylcholinesterase (BChE, horse-serum E.C 3.1.1.8) along with, acetylthiocholine iodide, butyrylthiocholine chloride, galanthamine and DTNB (5, 5´-dithiobis [2-nitrobenzoic-acid]) were purchased from Sigma. AChE and BChE inhibiting activities were measured according to modified spectroscopic method (Shojaaddini et al., 2008; Kavanagh, 1963; Ellman et al., 1961). All the protocol and assay conditions were the same as mentioned in the literature (Rocha et al., 1993). All other chemicals used in this assay were of analytical grade.

Briefly, 0.2 mM DTNB in 62 mM sodium phosphate buffer (pH 8.0, 880 μL), AChE/ BChE solution (40 μL) and test sample solution (40 μL) were mixed and incubated for 15 min (25ºC). To this mixture, 40 μL of acetylthiocholine or butyrylthiocholine were added to initiate the reaction. Hydrolysis of acetylthiocholine and butyrylthiocholine were monitored at a wavelength of 412 nm (15 min), by the formation of 5-thio-2-nitrobenzoate anion (yellow color), due to the enzymatic hydrolysis of acetylthiocholine/butyrylthiocholine, respectively. All the reactions were performed in triplicate in a BMS spectrophotometer(USA). The IC50 values were determined by monitoring the effect of increasing concentrations of these compounds in the assays on the inhibition values while acetylthiocholine iodide and butyrylthiocholine chloride were used as substrates in AChE and BChE assays.


Results

The IR spectrum of B. asiatica essential oil in chloroform showed major absorption at 3410 cm-1 and 1077 cm-1 which indicated hydroxyl group. The absorption appeared at 3008 cm-1, 886 cm-1 and 741 cm-1 were assigned for aromatic functional group. The absorption at 2924 cm-1 was indicative of aliphatic while absorption at 1681 cm- 1 was due to the presence of carbonyl functionalities.

The GC chromatogram obtained for leaves essential oil showed total of 17 peaks which appeared at varies retention indices/times. Both combined GC and MS studies resulted in the identification of 14 compounds. The scan numbers, retention time, compound names and their percentage abundances/quantities as well as other related results have been provided in Table I. The mass spectral data and retention times of the constituents were analyzed by the data system library and confirmed by comparison of their mass spectra using NIST mass spectral search program or Kovat’s Retention Index (RI).

Table I
GC/MS analysis of essential oil from leaves of Buddleja asiatica essential oil

Sl. No

R.I

Compound identified

M. F

% Abundance

m/z (%)

1

3.1

α –Pinene

C10H16

4.9

136, 121, 105, 93, 77, 65, 53, 41

2

3.8

α-Phellandrene

C10H16

5.8

136, 121, 107, 93, 77, 67, 55, 43

3

4.4

α –Thujene

C10H16

3.4

136, 121, 105, 93, 77, 65, 51, 41

4

5.3

1,8-cineole

C10H18O

38.1

154, 139, 107, 96, 81, 71, 68, 59, 43

5

6.3

Furan, 2-(1-pentenyl)-(E)

C9H12O

1.8

136, 121, 107, 93, 79, 65, 43

6

9.0

Terpinen-4-ol

C10H18O

1.9

154, 136, 111, 93, 86, 77, 71, 55, 43

7

9.6

Bicyclo[5.1.0]octane, 8-(1-methylethylidene)

C11H18

1.0

150, 139, 135, 121, 107, 96, 93, 81, 71, 67, 59, 55, 43

8

15.0

Eugenol

C10H12O2

1.5

164, 149, 137, 121, 103, 91, 77, 55

9

17.0

Kushimone

C14H20O

1.0

204, 189, 161, 147, 133, 121, 105, 91, 79, 67, 55

10

17.6

α –Cubebene

C15H23

1.4

204, 189, 174, 161, 147, 133, 119, 105, 91, 81, 67, 55

11

18.7

12-Nor-preziza-7(15)-en-2-one

C14H20O

1.8

204, 189, 173, 161, 136, 121, 107, 93, 81, 67, 55, 43

12

22.0

1,10-seco-1-hydroxycalamenen-10-one

C14H20O2

10.2

220, 202, 187, 177, 159, 147, 133, 119, 107, 95, 81, 69

13

22.0

Unidentified alcohol

C16H14O

4.0

222, 204, 189, 175, 161, 147, 133, 121, 107, 95, 81, 69

14

23.4

Isospathulenol

C15H24O

0.9

220, 205, 187, 177, 162, 147, 134, 119, 105, 93, 79, 69

15

23.8

Unknown diphenyl, di-ketone

C15H10O2

0.9

222, 204, 189, 177, 161, 147, 133, 121, 109, 95, 79, 69

16

26.0

β-Sinensal

C15H22O

11.8

218, 203, 189, 175, 161, 147, 133, 121, 107, 91, 79, 69

17

44.2

Unidentified

C18H17O2N

9.4

279, 248, 167, 149, 131, 113, 104, 97, 83, 71, 57, 43

Antibacterial activity of the B. asiatica essential oil was performed against even human pathogens including E. coli, B. subtilis, S. aureus, S. boydii, S. flexneri, P. aeruginosa and S. typhi.The essential oil displayed high to low activity in killing the S. boydi (56%), E. coli (44%), S. flexneri (36%), S. aureus (25%), B. subtilis (17%) and P. aeruginosa (10%) but no activity was seen against the S. typhi (Table II).

Table II
Antibacterial activities of B. asiatica essential oil

Bacteria

Imipenem
(Zone of inhibition)

Essential oil

Zone of inhibition

% Inhibition

E. coli

34

15

44

B. subtilis

30

5

17

S. aureus

28

7

25

S. boydii

25

14

66

S. flexneri

31

11

36

P. aeruginosa

30

3

10

S. typhi

29

B. asiatica essential oil displayed significant activity in killing A. flavus with 77% zone of inhibition (Table III). Optimum activity was observed against M. canis (66%), F. solani (60%) and T. longifusus (59%) while no activity were reported against C. glaberata and C. albicans.

B. asiatica essential oil revealed to be much potent towards AChE and BChE by inhibiting AChE and BChE in a dose dependent manner (Table IV). The IC50 values of essential oil was determined to be 5.2 μM and 27.9 against AChE and BChE respectively.

Table III
Antifungal activities of B. asiatica essential oil

Fungi

Linear growth (mm)
Control

B. asiatica essential oil

Standard drugs

Linear growth
(mm)

% Inhibition

Name

MIC
(μL/mL)

A. flavus

100

21

79

Amphotericin B

30

M. canis

100

70

66

Miconazole

105

T. longifusus

100

50

59

Miconazole

88

F. solani

100

40

60

Miconazole

94

C. glaberata

100

100

Miconazole

103

C. albicans

100

100

Miconazole

20

Table IV
AChE and BChE inhibitory activities of B. asiatica

AChE ± SEMa

BChE ± SEMa

Essential oil

5.2 ± 0.06

27.9 ± 0.03

Allanzanthaneb

6.9 ± 0.05

25.0 ± 0.06

Galanthamineb

7.9 ± 0.01

16.3 ± 0.01


Discussion

Our results showed that both monoterpenes and sesquiterpenes were detected in the leaves of essential oil. They included four monoterpenes hydrocarbons, four oxygenated monoterpenes, one hydrocarbon sesquiterpenes and five oxygenated sesquiterpenes. The major constituent being found was 1,8-cineole (38.1%) while β-sinensal, 1,10-seco-1-hydroxycalamenen-10-one and α-phellandrene were found to be 11.8%, 10.2%, 5.8% respectively. α-Pinene and α-thujene were present in 5.0% and 3.4%. While furan, 2-(1-pentenyl)-(E), terpinen-4-ol, bicyclo[5.1.0]octane, 8-(1-methylethylidene) and eugenol were found in traces. Because of the high content of monoterpenes, especially, 1,8-cineole, the oil may be classified as a medicinal type (Oyedeji et al., 1992). Other sesquiterpenes like isospathulenol, kushimone, 12-norpreziza-7(15)-en-2-one, α-cubebene, isospathulenol and germacrene-B were found in traces. Three of the constituents remain unidentified even from their molecular formulas due to the need of more spectroscopic evidences. In our continued search for biologically active constituents, we are interested to evaluate the AChE and BChE inhibiting potential of essential oils from herbal medicinal plants. Currently, AChE and BChE represent the most attractive target for drug design and discovery of mechanism-based inhibitors for the treatment of Alzheimer’s disease (Zhang, 2004). The percentage inhibition against AChE and BChE of B. asiatica essential oil was first determined at 0.1 mM and further subsequently assayed for IC50 determination. Due to phytochemical deviations between essential oil components, many essential oils differ in their anticholinesterase activities. Since essential oils were shown to be complex mixtures of a number of components with a high percentage of monoterpenes, especially the oxygenated monoterpenes, hence it is not conclusive to determine which single component is responsible for most of the biological activities. Several other studies have been carried out on the anticholinesterase activity of essential oils but the lack of sufficient knowledge has prompted us to work on this basis. In a recent study, essential oil of F. vulgare was tested for their AChE inhibitory activities (Mata et al., 2007) which revealed to be reasonably potent.

As compared to the AChE and BChE inhibitory effects of the single compounds of the essential oils, it may be deduced that the activity may not be due to a single compound. Similarly the essential oils of Melissa officinalis and Mentha suaveolens were reported to have strong AChE inhibitory activity. The anticholinesterase activity of several Mentha essential oils of Japanese origin were carried out (Miyazawa et al., 1998) in which, sesquiterpenes alcohols were the main components of these. Mentha oil showed the most potent inhibition. But none of them showed a stronger inhibitory activity than the essential oils. Although this was a report on a species different from ours, the difference in the activity may doubtlessly depend on chemical compositions.


Conclusion

The promising antimicrobial and anti-cholinesterase activities of the essential oil from B. asiatica are due to the presence of several minor multifunctional components, oxygenated mono and sesquiterpenes, specially 1,8-cineole and α-pinene

Click to see

Acknowledgment

The author is thankful to the financial support provided by higher education commission, Islamabad, Pakistan (HEC) through HEC 5000 PhD Fellowship program.


References

Abdullah P. Flora of Pakistan. Nasir E, Ali SI (eds). Stewart Herbarium Garden College (Rawalpindi) and Department of Botany, University of Karachi. 1974, pp 1–2.

Ali F, Ali I, Malik A, Stern B, Maitland DJ. Qualitative and quantitative assessment of various fatty acids from Buddleja asiatica. J Chem Soc Pak.2013; 33: 840-45,

Ali F, Ali I, Khan H, Khan A, Gilani AH. Studies on Buddleja asiatica antibacterial, antifungal, antispasmodic and Ca++ antagonist activities. A J Biotechnol. 2011; 10: 7679-83.

Ali F, Iqbal M, Naz R, Malik A, Ali I. Antimicrobial constituents from Buddleja asiatica. J Chem Soc Pak. 2011; 33: 90-96.

Ali F, Khan HU, Afzal M, Samad A, Khan SU, Ali I. Two new cholinesterase inhibitors, asiatoates A and B from Buddleja asiatica.J Asian Nat Prod Res. 2013; 15: 631-37.

Duraipandiyan V, Ignacimuthu S. Antibacterial and antifungal activity of flindersine isolated from the traditional medicinal plant, Toddalia asiatica (L.) Lam. J Ethanopharmacol. 2009; 123: 494-98.

El-Domiatya M, Winkb MM, Abou-Hashem AR. Antihepatotoxic activity and chemical constituents of Buddleja asiatica Lour. Z Nat Forsch C. 2009; 64: 11-19.

Ellman GL, Courtney KD, Andres VR, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7: 88-95.

Fathy MM, Al-Sofany RH, Kassem HA, Kandil ZA. Phytochemical and biological studies of certain Buddleja species growing in Egypt. Bull Fac Pharm. 2006; 44: 207-37.

Garg SC, Dengre SL. Composition of the essential oil from the leaves of Buddleia asiatica Lour. Flav Frag J. 1992; 7: 125-27.

Hartwell J. Plants used against cancer: A survey. Lloydia 1971; 34: 310-61.

Hegnauer R. Chemotonomie der Pfhmzen, Birkhauser. Basic 1962; 3: 308-09.

Hu K, Dong A, Sun Q, Yao X. Bioactivity of 247 traditional Chinese medicines against Pyricularia oryzae. Pharm Biol. 2001; 39: 47-53.

Dictionary of Chinese Traditional Medicine. Shanghai, Shanghai Science and Technology Press, 1977, p 725.

Kavanagh F. Analytical microbiology. New York, Academic Press, 1963, p 125.

Koroch A, Juliani H, Zygadlo J. Bioactivity of essential oils and their components. Flav Fragr Chem. 2007; 87-15.

Liao Y, Houghton P, Hoults J. Novel and known constituents from Buddleja species and their activity against leukocyte eicosanoid generation. J Nat Prod. 1999; 62: 1241-45.

Mata A,Proenc AC, Ferreira AR, Serralheiro ML, Noguheira JM, Araujoet ME. Antioxidant and antiacetylcholinesterase activities of five plants used as Portuguese food spices. Food Chem.2007; 103: 778-86.

Miyazawa M, Watanabe H, Umemoto K, Kameoka H. Inhibtion of acetylcholinesterase activity by essential oils of Mentha species. J Agric Food Chem. 1998; 46: 3431-34.

Oyedeji A, Olawore O, Ekundayo O, Koenig W. Volatile leaf oil constituents of three Eucalyptus species from Flavus ia. Flavor Fragr J. 1992; 14: 241-44.

Pande P, Tiwari L, Pande H. Ethnoveterinary plants of Uttaranchal: A review. Indian J Trad Knowl. 2007; 6: 444-58.

Rahman S, Imran M, Muhammad N, Hassan N, Chisthi A, Khan A, Sadozai K, Khan S. Antibacterial screening of leaves and stem of Carica papaya. J Med Plants Res. 2011; 5: 5167-71.

Reis A, Von S. Drugs and foods from little-known plants. Cambridge, Harvard University Press, 1973, pp 221-23.

Rocha JB, Emanuelli T, Pereira ME. Effects of early undernutrition kinetic parameters of brain acetylcholinesterase from adult rats. Acta Neurobiol Exp. 1993; 53: 431-37.

Shojaaddini M, Moharramipour S, Sahaf B. Fumigant toxicity of essential oil from Carum copticum against Indian meal moth, Plodia interpunctella. J Plant Prot Res. 2008; 48: 411-19.

Zhang X. Cholinergic activity and amyloid precursor protein processing in aging and Alzheimer’s diseases. Curr Drug Targets CNS Neurol Disord. 2004; 3: 137-52.